D.E. Shaw & Co’s Alaunos Therapeutics TCRT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,244
Closed -$231K 4163
2022
Q2
$231K Sell
1,244
-6,134
-83% -$1.14M ﹤0.01% 3342
2022
Q1
$722K Buy
7,378
+975
+15% +$95.4K ﹤0.01% 3040
2021
Q4
$1.05M Buy
6,403
+1,268
+25% +$207K ﹤0.01% 2717
2021
Q3
$1.4M Buy
5,135
+538
+12% +$147K ﹤0.01% 2302
2021
Q2
$1.82M Sell
4,597
-1,951
-30% -$773K ﹤0.01% 2141
2021
Q1
$3.54M Buy
6,548
+3,600
+122% +$1.94M ﹤0.01% 1533
2020
Q4
$1.11M Buy
2,948
+1,205
+69% +$455K ﹤0.01% 1980
2020
Q3
$659K Sell
1,743
-1,048
-38% -$396K ﹤0.01% 2026
2020
Q2
$1.37M Buy
+2,791
New +$1.37M ﹤0.01% 1784
2020
Q1
Sell
-902
Closed -$639K 2851
2019
Q4
$639K Buy
902
+551
+157% +$390K ﹤0.01% 2095
2019
Q3
$225K Sell
351
-1,622
-82% -$1.04M ﹤0.01% 2372
2019
Q2
$1.73M Buy
+1,973
New +$1.73M ﹤0.01% 1674
2019
Q1
Sell
-3,534
Closed -$991K 2726
2018
Q4
$991K Buy
3,534
+1,005
+40% +$282K ﹤0.01% 1849
2018
Q3
$1.21M Buy
2,529
+1,744
+222% +$837K ﹤0.01% 1753
2018
Q2
$356K Buy
785
+217
+38% +$98.4K ﹤0.01% 2261
2018
Q1
$334K Buy
568
+143
+34% +$84.1K ﹤0.01% 2212
2017
Q4
$264K Sell
425
-531
-56% -$330K ﹤0.01% 2308
2017
Q3
$880K Buy
956
+830
+659% +$764K ﹤0.01% 1845
2017
Q2
$117K Buy
+126
New +$117K ﹤0.01% 2311
2017
Q1
Sell
-103
Closed -$82K 2608
2016
Q4
$82K Sell
103
-54
-34% -$43K ﹤0.01% 2420
2016
Q3
$133K Buy
+157
New +$133K ﹤0.01% 2386
2016
Q1
Sell
-450
Closed -$560K 2724
2015
Q4
$560K Buy
450
+357
+384% +$444K ﹤0.01% 2025
2015
Q3
$126K Sell
93
-197
-68% -$267K ﹤0.01% 2428
2015
Q2
$522K Sell
290
-2,182
-88% -$3.93M ﹤0.01% 2153
2015
Q1
$3.99M Buy
2,472
+699
+39% +$1.13M 0.01% 1038
2014
Q4
$1.35M Buy
1,773
+1,469
+483% +$1.12M ﹤0.01% 1556
2014
Q3
$120K Sell
304
-244
-45% -$96.3K ﹤0.01% 2260
2014
Q2
$331K Buy
548
+254
+86% +$153K ﹤0.01% 2038
2014
Q1
$202K Sell
294
-362
-55% -$249K ﹤0.01% 2165
2013
Q4
$428K Buy
656
+570
+663% +$372K ﹤0.01% 2003
2013
Q3
$51K Buy
+86
New +$51K ﹤0.01% 2336